reference/18141301

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/18141301

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, N.I.H., Extramural\|Research Support, Non-U.S. Gov't
endingPage	1526
issn	1091-6490 0027-8424
issueIdentifier	4
pageRange	1521-1526
publicationName	Proceedings of the National Academy of Sciences of the United States of America
startingPage	1521
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_c81c82b4ad9caa060230b3c9689699b7 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_fa30e56dc70de67dbc49ab51117cff85 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_3762d38dab3b4c570bb358b81e7e32f9 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_add4a196df6c97c6bcf4d8e3bbb747de http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_251c0f6a6fec9d074c5f06c78696b626
bibliographicCitation	Li W, Ai N, Wang S, Bhattacharya N, Vrbanac V, Collins M, Signoretti S, Hu Y, Boyce FM, Gravdal K, Halvorsen OJ, Nalwoga H, Akslen LA, Harlow E, Watnick RS. GRK3 is essential for metastatic cells and promotes prostate tumor progression. Proc Natl Acad Sci U S A. 2014 Jan 28;111(4):1521–6. PMID: 24434559; PMCID: PMC3910602.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9fc9bede51216e5cb1c0d0f185ed01a1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_663d7ddd6b7a6395904faddd90db7fdf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c81af02f8d1da24430f42a9a2c1be1c6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9663a4b838605e0214fdcd53edc92fad http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_44b57a6ba85ae640852c5ac945dc5459 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_593ba90c0a26e2829293a0ebb1effa1a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_56bd0fb5f6271389c1d083a7f41f2346 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6ee1d0635ba98cacf8268714fa137eb4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4e0a4fd535c4f84343e9e7d565c10117 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_403b02e1a8d24f277a9ab509fa0fa1cb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b56057cc7206dbfcd993481af58bab9f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_36be4e7bd4ab0359d5b44fb1274dbb4d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_801c6ffdc5e8953918fbd528c7e1c117 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_600e08f735f1c91ee4e0e940702fe8c3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_24af1bcf900f498a01f0a1f317dec7d7
date	2014-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1073/pnas.1320638111 https://pubmed.ncbi.nlm.nih.gov/PMC3910602 https://pubmed.ncbi.nlm.nih.gov/24434559
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/6653 https://portal.issn.org/resource/ISSN/0027-8424 https://portal.issn.org/resource/ISSN/1091-6490
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	GRK3 is essential for metastatic cells and promotes prostate tumor progression
discusses	http://id.nlm.nih.gov/mesh/M0244212 http://id.nlm.nih.gov/mesh/M0029254 http://id.nlm.nih.gov/mesh/M0026410 http://id.nlm.nih.gov/mesh/M0471704
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D011471Q000473 http://id.nlm.nih.gov/mesh/D054770Q000502 http://id.nlm.nih.gov/mesh/D009362
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D049109 http://id.nlm.nih.gov/mesh/D017396Q000235 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D011471Q000378 http://id.nlm.nih.gov/mesh/D018450 http://id.nlm.nih.gov/mesh/D019700Q000235
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8983 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_91c4c0571c43ff7132ee5377f5a4bfa6 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_25dd6a52e9ad20f76126de5c13624149

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID157

Total number of triples: 61.